MERIT Act

Bill: 118-hr-133
Sponsor: full_name: Rep. Buchanan, Vern [R-FL-16]
Introduced: 2023-01-09
Policy area: Health
Subjects: Medical research

Medicare

Prescription drugs
Latest action: action_date: 2024-12-19
text: Placed on the Union Calendar, Calendar No. 779.

Summaries:
action_date: 2023-01-09
action_desc: Introduced in House
text: <p><b>Mandating Exclusive Review of Individual Treatments (MERIT) Act</b></p> <p>This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.</p>

tv_txt: IB Union Calendar No. 779 118th CONGRESS 2d Session H. R. 133 [Report No. 118–764, Part I] IN THE HOUSE OF REPRESENTATIVES January 9, 2023 Mr. Buchanan (for himself, Ms. Barragán , and Ms. Salazar ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned November 22, 2024 Reported from the Committee on Energy and Commerce with an amendment Strike out all after the enacting clause and insert the part printed in italic November 22, 2024 Referral to the Committee on Ways and Means extended for a period ending not later than December 19, 2024 December 19, 2024 Additional sponsors: Mr. Fitzpatrick , Mr. Ferguson , Mr. Carey and Mrs. Miller of West Virginia December 19, 2024 Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed For text of introduced bill, see copy of bill as introduced on January 9, 2023 A BILL To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.

1. Short title This Act may be cited as the Mandating Exclusive Review of Individual Treatments Act or the MERIT Act . 2. Clarification on Medicare national coverage determination process Section 1862(a) of the Social Security Act ( 42 U.S.C. 1395y(a) ) is amended by adding at the end the following new sentence: For purposes of paragraph (1)(E), with respect to a determination made on or after the date of the enactment of this sentence of whether a drug or biological is reasonable and necessary to carry out the purposes of such section, such determination shall be made with respect to each drug or biological involved and not with respect to a class of drugs or biologicals. .

December 19, 2024 Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed

tv_txt: I 118th CONGRESS 1st Session H. R. 133 IN THE HOUSE OF REPRESENTATIVES January 9, 2023 Mr. Buchanan (for himself, Ms. Barragán , and Ms. Salazar ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.

1. Short title This Act may be cited as the Mandating Exclusive Review of Individual Treatments (MERIT) Act . 2. Clarification on Medicare national coverage determination process Section 1862(a) of the Social Security Act ( 42 U.S.C. 1395y(a) ) is amended by adding at the end the following new sentence: For purposes of paragraph (1)(E), in the case of research conducted pursuant to section 1142, the determination of whether a drug or biological is reasonable and necessary to carry out the purposes of section 1142 shall be made with respect to each drug or biological involved and not with respect to a class of drugs or biologicals. .